Market Research Logo

Juniper Pharmaceuticals Inc (JNP) - Financial and Strategic SWOT Analysis Review

Juniper Pharmaceuticals Inc (JNP) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company utilizes proprietary drug delivery technologies to treat various medical conditions to commercial partners. Its proprietary technology includes intravaginal ring (IVR) and bioadhesive gel (BDS). Juniper provides a range of drug development services and consulting services to the pharmaceutical industry. The company operates in pharmaceutical industry and also provides in-house expertise for internal pharmaceutical programs. The company operates in the US, the UK, Switzerland and other countries. Juniper is headquartered in Boston, Massachusetts, the US.

Juniper Pharmaceuticals Inc Key Recent Developments

May 10,2018: Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results
Mar 21,2018: Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors
Mar 08,2018: Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results
Jan 31,2018: Juniper Pharmaceuticals to Explore Strategic Alternatives
Jan 02,2018: Juniper Pharma Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Juniper Pharmaceuticals Inc - Key Facts
Juniper Pharmaceuticals Inc - Key Employees
Juniper Pharmaceuticals Inc - Key Employee Biographies
Juniper Pharmaceuticals Inc - Major Products and Services
Juniper Pharmaceuticals Inc - History
Juniper Pharmaceuticals Inc - Company Statement
Juniper Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Juniper Pharmaceuticals Inc - Business Description
Business Segment: Product
Overview
Performance
Business Segment: Service
Overview
Performance
Geographical Segment: Other countries
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
Juniper Pharmaceuticals Inc - Corporate Strategy
Juniper Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Juniper Pharmaceuticals Inc - Strengths
Juniper Pharmaceuticals Inc - Weaknesses
Juniper Pharmaceuticals Inc - Opportunities
Juniper Pharmaceuticals Inc - Threats
Juniper Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Juniper Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 10, 2018: Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results
Mar 21, 2018: Juniper Pharmaceuticals Appoints Richard Messina to Board of Directors
Mar 08, 2018: Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results
Jan 31, 2018: Juniper Pharmaceuticals to Explore Strategic Alternatives
Jan 02, 2018: Juniper Pharma Outlines Strategic Priorities for 2018 and Reports Recent Portfolio Progress
Nov 02, 2017: Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results
Sep 18, 2017: Juniper Pharmaceuticals Announces Strategic Reprioritization
Sep 11, 2017: Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors
Sep 11, 2017: Juniper Pharmaceuticals Appoints Jennifer Good to Board of Directors
Aug 08, 2017: Major Progress in Next Generation Medicines Initiative
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Juniper Pharmaceuticals Inc, Key Facts
Juniper Pharmaceuticals Inc, Key Employees
Juniper Pharmaceuticals Inc, Key Employee Biographies
Juniper Pharmaceuticals Inc, Major Products and Services
Juniper Pharmaceuticals Inc, History
Juniper Pharmaceuticals Inc, Subsidiaries
Juniper Pharmaceuticals Inc, Key Competitors
Juniper Pharmaceuticals Inc, Ratios based on current share price
Juniper Pharmaceuticals Inc, Annual Ratios
Juniper Pharmaceuticals Inc, Annual Ratios (Cont...1)
Juniper Pharmaceuticals Inc, Annual Ratios (Cont...2)
Juniper Pharmaceuticals Inc, Interim Ratios
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Juniper Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Juniper Pharmaceuticals Inc, Performance Chart (2013 - 2017)
Juniper Pharmaceuticals Inc, Ratio Charts
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Juniper Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report